TSLP and asthma: An impaired skin barrier promotes release of proinflammatory epithelial-derived cytokines, IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), which initiate and propagate Type 2 inflammatory responses in AD, food-hypersensitivity reactions, and asthma [16].